The article you requested is
Self-Medication, Bipolar Disorders, and Stimulant Dependence
J Clin Psychiatry 2009;70(6):935-936
Copyright 2009 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Sir: In the August 2008 issue of the Journal, Nejtek et
al. present findings that both quetiapine and risperidone
produced improvement in manic, mixed, and depressive symptoms.
In turn, symptom reduction was associated with reduced
drug cravings in patients with co-occurring bipolar and stimulant
dependence disorders, albeit not affecting drug use. These
are important findings in that (1) there is an extraordinarily
high incidence of co-occurrence of substance abuse in general
associated with bipolar disorders and, in particular, a high cooccurrence
of stimulant abuse; and (2) there are few if any specific
effective psychopharmacologic treatments for stimulant dependence.